Interested in how chronic inflammation develops. Drug development. B cells. Rheumatoid arthritis. And much more
Birmingham, England
Joined January 2013
- Tweets322
- Following191
- Followers84
- Likes344
Dagmar Scheel-Toelln retweeted
Well that was a lovely visit to Birmingham Uni/Queen Elizabeth Hospital today, where we @VersusArthritis have made significant investment in research&fellowships. Some gr8 presentations & engaging visit around the labs.
Huge thanks for the hospitality and warm welcome.
Dagmar Scheel-Toelln retweeted
Day 2 @VersusArthritis research fellows conference. Such bright minds & bringing gr8 hope for the future. Prof Matthew Brown, Chief Scientific Officer for @GenomicsEngland (funded by us since 1996!) talked about getting closer to a cure for AxSpa. Imagine that. Yes please. 🥰
Dagmar Scheel-Toelln retweeted
Absolutely brilliant day of truly cutting edge science. Thanks so much to all presenters and attendees. It’s hard to imagine where you could find a denser concentration of state-of-the-art arthritis research @NHIPartners @NuTHResearch @NIHRNewcBRC @NIHR_Newc_CRF @UniofNewcastle
Dagmar Scheel-Toelln retweeted
Final session - AuToDeCRA-2 (technologies) chaired by Adam Croft @APCroft Final year RACE PhD student Jean-Baptiste Richard @jbrcad delivered a very interesting talk on “Matrix-focused multiomic analysis uncovers a novel regulator of the synovial immune landscape” Well done JB!👏
Dagmar Scheel-Toelln retweeted
Session 2 – TRAFIC (stroma) chaired by Chris Buckley @arthritisbham with RACE student Imogen Wilson @Imy_wilsongiving giving a brilliant talk on “The functional consequences of B cell and fibroblasts interactions” 👏
Dagmar Scheel-Toelln retweeted
Iain McInnes chaired session 1 on BIO-FLARE (cells and cytokines) @IainBMcInnes1 We had some fascinating talks! Here is Dr Dan Maunder @Maunderific1
presenting on scRNA-Seq from BIO-FLARE PBMC
Dagmar Scheel-Toelln retweeted
Excited to be attending the RACE Hybrid Scientific meeting today hosted by University of Newcastle! @ProfJohnIsaacs We have some fantastic talks lined up from our @Racegbn colleagues! @KirOxford @RRG_Birmingham @MRGNewcastle @UofGSii @VersusArthritis
Dagmar Scheel-Toelln retweeted
We're delighted to award 3 BSI members Lifetime Honorary Membership at #BSI23 @bsicongress in recognition of their outstanding contributions to #immunology ⭐
🏆2023 Honorary Members🏆
Prof Arne Akbar @AkbarLab
Prof Allan Mowat @mowat_allan
Dr Gitta Stockinger @TheCrick
Dagmar Scheel-Toelln retweeted
Many congratulations to our rising star Sally Clayton, very well deserving winner of a Wellcome Trust Early Career Award 👏👏👏⭐️
I'm thrilled to learn that I've been awarded a Wellcome Trust Early Career Award, which will fund my research for the next 5 years! 🥂🎉 Super excited to work with @SarahDimeloeLab and @ImmunologyUoB to understand how mitochondrial regulation controls immune cells in inflammation
Dagmar Scheel-Toelln retweeted
I'm thrilled to learn that I've been awarded a Wellcome Trust Early Career Award, which will fund my research for the next 5 years! 🥂🎉 Super excited to work with @SarahDimeloeLab and @ImmunologyUoB to understand how mitochondrial regulation controls immune cells in inflammation – at Birmingham, England
Dagmar Scheel-Toelln retweeted
Excited 🎉 to share our recent work: STew🍲, a Spatial Transcriptomic multi-viEW representation learning method, to jointly characterize the gene expression variation and spatial information🧬💻. Led by our lab members Nanxi, Juan, Douglas, and Revanth: biorxiv.org/content/10.1101/…
Dagmar Scheel-Toelln retweeted
It’s a match: Birmingham leads pioneering initiative to partner PhD students and patients birmingham.ac.uk/news/2023/i… via @unibirmingham
Dagmar Scheel-Toelln retweeted
🔥 Just out! 📷
In today's publication by @BMC_series , we present the Student Patient Alliance. This groundbreaking #PPI initiative, led by @DrMarieFalahee, connects PhD students with patient, revolutionizing collaboration in Birmingham.
@R2P2_UoB
@BirminghamBRC
Dagmar Scheel-Toelln retweeted
If you have #lupus and live in the UK we need your help with this LUPUS UK-funded study! @LUPUSUK #lupusawarenessmonth @InflamAge_UoB
This LUPUS UK - funded study investigating exercise & lifestyle in people with #SLE is looking for a few more participants before it closes. You can take part here: bham.onlinesurveys.ac.uk/lif…
Thank you to everyone who has already taken part!
ALT Study on exercise and lifestyle in lupus recruiting now
Dagmar Scheel-Toelln retweeted
We are excited to bring you a fantastic line-up of speakers for our 🌟Triggers of Autoimmunity🌟1-day online event on 26th Oct. Only 7 days left to register & submit your abstracts!
Have you submitted your #AutoimmunityTriggers23 abstract yet?
Speakers include Prof @cameron_wraith, Prof @danaorange, Dr @PiaLeete, Prof @s_milling, Prof Claudia Mauri @Mauri_group, Prof Alberto Ascherio & Prof Ignacio Sanz 🙌
Deadline: Fri 22 Sept 👉bit.ly/45mchUQ
Dagmar Scheel-Toelln retweeted
We are opening participant recruitment for our #STRAVINSKYstudy. As we do so, we want to provide info on how you can find out more about our research & how to get involved 1/🧵
1. Visit our website & read our info on participant recruitment👉 immunology.org/partnerships/…
Dagmar Scheel-Toelln retweeted
Please join our wonderful Patient Involvement in Research group @R2P2_UoB if you have Rheumatoid Arthritis. Your input is fundamental to us ! #ExpertsByExperience #PPIE birmingham.ac.uk/r2p2
In celebration of Rheumatoid Arthritis (RA) Awareness Week #RAAW we are appealing for new members! If you have RA and want to have a say in @RRG_Birmingham research come and join us! #ExpertsByExperience #PPIE @InflamAge_UoB @BirminghamBRC
Dagmar Scheel-Toelln retweeted
The awesome power of @BTA_Birmingham multidimensional digital histology and Ai platforms being showcased by our Technicians Chelsea, Dawn, Jordanne and Nayandeep @InflamAge_UoB @Racegbn @RRG_Birmingham
Dagmar Scheel-Toelln retweeted
Understanding what risk/benefit trade-offs are acceptable to patients is important in drug development. How best to assess this? Our paper compares two methods for measuring patient preferences. @RRG_Birmingham @InflamAge_UoB @BirminghamBRC @IMI_PREFER
pubmed.ncbi.nlm.nih.gov/3764…
